|
FAM175B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08721928629529E-14 |
| Normal-vs-Stage2 |
1.9744000001598E-07 |
| Normal-vs-Stage3 |
1.15463194561016E-13 |
| Normal-vs-Stage4 |
1.96698213272839E-12 |
| Stage1-vs-Stage2 |
7.695000E-01 |
| Stage1-vs-Stage3 |
1.439170E-01 |
| Stage1-vs-Stage4 |
3.120200E-02 |
| Stage2-vs-Stage3 |
2.259600E-01 |
| Stage2-vs-Stage4 |
5.861800E-02 |
| Stage3-vs-Stage4 |
3.423600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
7.70380000000292E-05 |
| Normal-vs-Asian |
7.14540004942421E-09 |
| Caucasian-vs-AfricanAmerican |
2.129800E-01 |
| Caucasian-vs-Asian |
4.547200E-01 |
| AfricanAmerican-vs-Asian |
5.366800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21125331986605E-13 |
| Normal-vs-Female |
1.62503344114384E-12 |
| Male-vs-Female |
4.700200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.00814928522186E-12 |
| Normal-vs-Age(41-60Yrs) |
2.1538326677728E-14 |
| Normal-vs-Age(61-80Yrs) |
2.39386288569676E-12 |
| Normal-vs-Age(81-100Yrs) |
5.363800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.553600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.335000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.455800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.028000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.807600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.051400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.007370E-01 |
| Classical-VS-Follicular |
8.982200E-01 |
| Classical-VS-Other |
1.993590E-01 |
| Classical-VS-Normal |
1.62725388719309E-12 |
| Tall-VS-Follicular |
1.178840E-01 |
| Tall-VS-Other |
6.600800E-01 |
| Tall-VS-Normal |
4.34729996445782E-09 |
| Follicular-VS-Other |
2.825600E-01 |
| Follicular-VS-Normal |
1.33469999497038E-08 |
| Other-VS-Normal |
2.767800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.07052211118753E-14 |
| Normal-vs-N1 |
1.08357767203415E-12 |
| N0-vs-N1 |
4.877600E-02 |
|
|
